Cangene (FRA:YGE) Days Payable : 0.00 (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Days Payable?

Cangene's average Accounts Payable for the three months ended in Oct. 2013 was €0.00 Mil. Cangene's Cost of Goods Sold for the three months ended in Oct. 2013 was €11.43 Mil. Hence, Cangene's Days Payable for the three months ended in Oct. 2013 was 0.00.

The historical rank and industry rank for Cangene's Days Payable or its related term are showing as below:

FRA:YGE's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 147.17
* Ranked among companies with meaningful Days Payable only.

Cangene's Days Payable stayed the same from Oct. 2012 (0.00) to Oct. 2013 (0.00). stayed the same

Cangene Days Payable Historical Data

The historical data trend for Cangene's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Days Payable Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Days Payable

Get a 7-Day Free Trial

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cangene's Days Payable

For the Biotechnology subindustry, Cangene's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cangene's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Days Payable distribution charts can be found below:

* The bar in red indicates where Cangene's Days Payable falls into.

Cangene Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cangene's Days Payable for the fiscal year that ended in Jul. 2013 is calculated as

	Days Payable (A: Jul. 2013 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jul. 2012 )	+	Accounts Payable (A: Jul. 2013 ))	/	count )	/	Cost of Goods Sold (A: Jul. 2013 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	57.322	*	365
=	0					/	57.322	*	365
=	0.00

Cangene's Days Payable for the quarter that ended in Oct. 2013 is calculated as:

	Days Payable (Q: Oct. 2013 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jul. 2013 )	+	Accounts Payable (Q: Oct. 2013 ))	/	count )	/	Cost of Goods Sold (Q: Oct. 2013 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	11.427	*	365 / 4
=	0					/	11.427	*	365 / 4
=	0.00

Cangene Days Payable Related Terms

Thank you for viewing the detailed overview of Cangene's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines